A high expression level of CDKN1A was strongly associated with the exacerbation of NAFLD fibrosis and predicted a poor prognosis in both animal experiments and human NASH samples (41, 42), which was supported by our findings. This evidence concerns the gene CDKN1A and metabolic dysfunction-associated steatotic liver disease.